We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01644877
Brief Title: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen (DAS181-2-05)

First Submitted : July 17, 2012
First Submitted that Met QC Criteria : July 18, 2012
First Posted : July 19, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : September 21, 2017
Last Update Posted : September 25, 2017